U.S. Department of Health and Human Services Deploys Palantir AI Tools to Screen DEI and Gender Issues in Grants

Introduction: AI Tools Enter the Frontier of Government Review

In the grant review process of the U.S. Department of Health and Human Services (HHS), AI technology is playing an increasingly significant role. According to a report by WIRED journalist Caroline Haskins, since March 2025, HHS has deployed tools from Palantir and Credal AI to identify and exclude grant applications deemed related to "DEI" (Diversity, Equity, and Inclusion) or "gender ideology." This initiative marks a deep penetration of AI from commercial data analysis into government policy execution, sparking intense debate over free speech, technological neutrality, and political intervention.

'Since March 2025, the Department of Health and Human Services has been using tools from Palantir and the startup Credal AI to weed out content perceived as supporting "DEI" or "gender ideology."' — Excerpt from the original article

Palantir and Credal AI: The Giants and Newcomers Behind the Technology

Palantir Technologies, a data analytics company founded in 2003 by Peter Thiel and others, is renowned for its powerful big data platforms. The company has previously served U.S. intelligence agencies and Immigration and Customs Enforcement (ICE), helping track immigration data, and has long been a subject of controversy. Palantir's Gotham and Foundry platforms excel at processing massive unstructured data, using natural language processing (NLP) and machine learning algorithms to quickly scan text, extract keywords, and generate risk scores.

In contrast, Credal AI is an emerging startup focused on enterprise-grade AI data governance and compliance tools. Its platform emphasizes "data observability," monitoring AI model inputs and outputs to detect sensitive content such as bias or policy violations. In the HHS application, these tools are likely integrated for automated grant proposal review: the algorithm scans applications for terms like "gender fluidity," "non-binary gender," or DEI-related keywords, flagging them as high-risk once a threshold is met.

From an industry perspective, the use of AI in government grant review is not entirely new. As early as 2020, the National Science Foundation (NSF) introduced AI-assisted review to improve efficiency. However, the HHS deployment is more targeted, directly aimed at specific ideologies, aligning with the anti-DEI wave during the Trump administration. After the 2024 election, the new government pushed forward "anti-woke" policies. As the largest federal health funding agency, HHS has an annual budget exceeding $160 billion, and its AI screening will directly impact medical research and public health programs.

DEI and Gender Ideology: The Core of Controversy

DEI initiatives originated from the corporate diversity movement of the 1990s, aimed at promoting workplace equity. However, in recent years, they have faced severe criticism from U.S. conservatives, who accuse them of "reverse discrimination." Similarly, "gender ideology" often refers to LGBTQ+-related issues, such as transgender healthcare and gender education in schools, which may appear in grant applications for mental health research or community projects.

HHS officials state that this measure is intended to ensure taxpayer funds are not used for "non-scientific" agendas but are focused on core health needs. However, critics view it as a form of political purge. While keyword matching by AI tools is efficient, it ignores context: a proposal on mental health research might be rejected simply for mentioning "gender diversity," thereby distorting the direction of scientific inquiry.

Editor's Note: The Double-Edged Sword of AI Politicization

As an AI tech news editor, I believe this practice by HHS highlights the urgency of AI governance. On one hand, automated review can improve efficiency and reduce human bias; on the other hand, when algorithms are infused with political preferences, they amplify divisions. Palantir's military background has already raised privacy concerns, and this application could trigger lawsuits: Do grant applicants have the right to know the basis of AI decisions? How can algorithmic transparency be ensured?

On a broader level, global AI regulation is accelerating. The EU's AI Act classifies high-risk applications as a priority, and the U.S. Federal Trade Commission (FTC) is investigating Palantir for antitrust issues. In China, AI ethics emphasize "algorithm filing," a practice worth referencing. In the future, HHS must disclose algorithmic details to avoid "black box" operations; otherwise, public trust in technology will be eroded.

Potential Impacts and Industry Reactions

This policy has already affected academia. Several university research teams report a sudden drop of over 20% in funding rates for DEI-related projects. In the biomedical field, research on equity in cancer screening, for example, may be hindered if it touches on DEI. At the same time, startups like Credal AI benefit greatly, with valuations potentially soaring due to government contracts.

Expert opinions are divided: Timnit Gebru, an AI ethics professor at Stanford University, warns that "AI censorship will create an echo chamber effect and stifle innovation," while the conservative Heritage Foundation praises it for "restoring rationality." Technically, such tools rely on training data; if the datasets lean toward conservative narratives, the output will be biased.

Looking ahead, as the 2026 midterm elections approach, similar AI applications may expand to the Department of Education and the Department of Justice. Companies need to be cautious: Palantir's stock price has already risen by 5% due to government orders, but reputational risks persist.

Conclusion: Balancing Innovation and Values

The HHS AI screening experiment reminds us that technology is not neutral. How to balance efficiency and fairness will test the wisdom of U.S. AI policy.

This article is compiled from WIRED, by Caroline Haskins, dated February 3, 2026.